小鼠抗NAPSA單克隆抗體

Background:

The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus. [provided by RefSeq, Jul 2008].

Applications:

IHC, IF

Name of antibody:

NAPSA

Immunogen:

Fusion protein of human NAPSA

Full name:

napsin A aspartic peptidase (NAPSA)

Synonyms:

KAP; Kdap; NAP1; NAPA; SNAPA

SwissProt:

O96009

IHC positive control:

adenocarcinoma of human ovary tissue and carcinoma of human prostate tissue

IHC Recommend dilution:

30-150

IF Positive control:

TT cells

IF Recommended dilution:

50-100